Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anticancer Research|September 29, 2023
The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma PatientsMichael Tassavor, Brian J Martin, Alex M Glazer
Journal of Drugs in Dermatology : JDD|June 20, 2017
Impact of a 31-gene Expression Profiling Test for Cutaneous Melanoma on Dermatologists' Clinical Management DecisionsAaron S Farberg, Alex M Glazer, Richard White, et al.
Dermatologic Clinics|September 10, 2017
Assessing Genetic Expression Profiles in Melanoma PrognosisAaron S Farberg, Alex M Glazer, Richard R Winkelmann, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Successful Treatment of Generalized Essential Telangiectasia With 6-MercaptopurineAlex M Glazer, Bryan D Sofen, Darrell S Rigel, et al.
Dermatologic Clinics|September 10, 2017
Clinical Diagnosis of Skin Cancer: Enhancing Inspection and Early RecognitionAlex M Glazer, Darrell S Rigel, Richard R Winkelmann, et al.
Journal of Drugs in Dermatology : JDD|May 10, 2018
Factors Affecting Dermatologists' Use of a 31-Gene Expression Profiling Test as an Adjunct for Predicting Metastatic Risk in Cutaneous MelanomaRyan M Svoboda, Alex M Glazer, Aaron S Farberg, et al.
Dermatologic Clinics|September 10, 2017
Noninvasive Technologies for the Diagnosis of Cutaneous MelanomaRichard R Winkelmann, Aaron S Farberg, Alex M Glazer, et al.
Cutis|June 13, 2018
Enhanced melanoma diagnosis with multispectral digital skin lesion analysisAaron S Farberg, Alex M Glazer, Richard R Winkelmann, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 31, 2018
Melanoma Reporting Practices of United States DermatologistsRyan M Svoboda, Alex M Glazer, Aaron S Farberg, et al.
Pageof 2